ClinicalTrials.gg
RecruitingNCT05559463Updated Nov 5, 2026

Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis

An interventional study of ITIS diet in Osteoarthritis, Knee, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Oct 2021, registered Sep 2022).
  • Started Oct 2021; still recruiting 5 years 1 month later.
Updated Nov 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 796 studies in Osteoarthritis, Knee with a site in United States — 109 open to participants now, 152 under way, 15 of them phase 3. Osteoarthritis, Knee · United States.

Planned enrollment
523rd of 691
30 · median 72
Started
2021
with 59 others
No phase
376 of 796
54 open now
Primary completion
2027-01
later than 57 of 151 live
Registered
652nd of 796
by date

Among the 796 studies in Osteoarthritis, Knee with a site in United States, this one is the 523rd largest by planned enrollment of the 691 interventional ones that give a count, is one of 60 that started in 2021, is one of 376 with no phase, reaches primary completion later than 57 of the 151 other live ones, and was the 652nd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

109 of the 796 studies in Osteoarthritis, Knee with a site in United States are open now. Recruiting first, the newest first:

104 more — sign in →

All 109 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 796 studies in Osteoarthritis, Knee with a site in United States, or all of them as a file.
02

Study summary

To study the effect of anti-inflammatory diet on clinical and biological outcomes in patients with knee osteoarthritis

Read the detailed description

The investigators would like to evaluate how inflammation occurs in the joints of subjects with osteoarthritis, and identify molecules and bacteria that can predict whether a patients with knee osteoarthritis will have more or less pain . Blood, urine and stool will be evaluated in the laboratory and compared to their own samples after changes in diet. This is an exploratory study, which is meant to gather preliminary data about the quick effects of changes in diet and treatment on molecules in blood/urine and bacteria in stools. These studies can provide clues to the cause of disease and might ultimately lead to new therapies.

03

Conditions studied

  • Osteoarthritis, Knee
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients diagnosed of Knee Ostoeaarthritis
  • without changes in treatment in the last 3 months

Exclusion criteria

Exclusion Criteria:

  • food allergies
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    ITIS diet

    anti-inflammatory (ITIS) diet for 28 days

    Dietary Supplement: ITIS diet

Interventions

  • Dietary supplementITIS diet

    anti-inflammatory (ITIS) diet for 28 days

06

What researchers measure

Primary outcomes

  1. Change of baseline pain measured by visual analogue scale (0-10) after 28 days

    Change of baseline pain measured by visual analogue scale (0-10) after 28 days, being 0 no pain, and 10 the worse outcome

    Time frame: 28 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Sala-Climent M, Bu K, Coras R, Cedeno M, Zuffa S, Murillo-Saich J, Mannochio-Russo H, Allaband C, Hose MK, Quan A, Choi SI, Nguyen K, Golshan S, Blank RB, Holt T, Lane NE, Knight R, Scher J, Dorrestein P, Clemente J, Guma M. Targeted Microbial Shifts and Metabolite Profiles Were Associated with Clinical Response to an Anti-Inflammatory Diet in Osteoarthritis. Nutrients. 2025 Aug 22;17(17):2729. doi: 10.3390/nu17172729. PubMed 40944120 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for Jan 2027, 63 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 63 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jan 2026 → Jan 2027 and completion Oct 2026 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2022
First posted
Sep 29, 2022
StartActual
Oct 1, 2021
Primary completionEst.
Jan 1, 2027was Jan 2026
CompletionEst.
Oct 1, 2027was Oct 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 1, 2026→Jan 1, 2027
Nov 5, 2026
Study completion
Oct 1, 2026→Oct 1, 2027
Nov 5, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 40944120 ↗
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 40944120 ↗
    Primary completion Jan 1, 2026→Jan 1, 2027
    Study completion Oct 1, 2026→Oct 1, 2027
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05559463
Responsible party
Monica Guma (Associate Professor of Medicine, University of California, San Diego) — Principal investigator
First posted
Sep 29, 2022
Start date
Oct 1, 2021
Primary completion
Jan 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Monica Guma, MD, PhD
Contact
mguma@ucsd.edu
8588226523

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion